Christopher Kemp, PhD

faculty member

Christopher Kemp, PhD

Human Biology Division, Fred Hutch

Public Health Sciences Division, Fred Hutch

Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Fax: 206.667.5815
Mail Stop: C1-015

Dr. Christopher Kemp works to make the promise of precision oncology a reality. His goal is to develop targeted therapies — treatments that not only target a specific individual’s tumors, but that target tumors while sparing healthy tissue. He and his team have developed an approach to identify the next generation of precision cancer therapeutics that draws on patient tumor samples. It integrates molecular information from tumor genomics with cancer cell’s sensitivity to potential drugs. The team is applying the strategy to cancers including pancreatic, ovarian, breast, and head and neck cancer. Dr. Kemp is a member of the Cancer Target Discovery and Development Network, a multi-institutional collaborative effort designed to bridge the knowledge gap between cancer genomics and precision oncology.

Other Appointments & Affiliations

Affiliate Professor, Pathology
University of Washington School of Medicine


PhD, Oncology, University of Wisconsin-Madison, 1989

MS, Fisheries Science, Oregon State University, 1984

BA, Biology, Case Western Reserve University, 1980

"By teaming up with experts with a range of experience, we will be able to translate our findings to the clinic much faster. I’m more optimistic than ever before."

 — Dr. Christopher Kemp

Find a Clinical Trial Led by Dr. Kemp

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210